The first rural hospital to line up for the life of the new government

Published Date: 08 Mar 2023

Hospitals in New Mexico, Texas and Oklahoma are the first to call for a new rural hospital payment model that shifts services from inpatients to outpatients and emergency patients.

Read Full News

Latest News

Systemic Onychomycosis Rxs: Hepatoxicity Risks Compared

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Latest News

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

News All Time

Early Oral Antibiotics: A Safe Shift in Bone Infections

Early switching from intravenous to oral treatment does not compromise treatment success in children with bone and joint infections and may reduce the risk for complications.

AD Not Linked to Poor Academic Performance in Adolescents

Atopic dermatitis does not significantly impair academic performance, a study finds.

High-Flow Oxygen Slightly Reduces Intubation, Not Mortality

High-flow nasal oxygen appears to reduce intubation incidence but does not reduce mortality in ICU patients with acute hypoxemic respiratory failure.

Sunscreen Use Has Doubled Among Black Individuals

The rate at which individuals with darker skin tones take steps to protect themselves from the sun has doubled in 20 years, but there is a great distance to go.

Dermatologist’s Guide to Patients With Personality Disorders

Reassurance, routine, and respect are key to navigating difficult encounters.

Biomarkers Track AD Severity in Children

Serum thymus and activation-regulated chemokine and squamous cell carcinoma antigen 2 are superior to total IgE or eosinophils in assessing atopic dermatitis severity, a retrospective study finds.

Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?

Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.

Growth in Sector, Private Equity Fuel Hospitalist Lawsuits

Malpractice claims against hospitalists highest of any specialty.

Predicting Early Death in Immunocompromised Status With ARF

In immunocompromised patients with acute hypoxemic respiratory failure, frailty and longer hospital-to-ICU time may raise 30-day mortality, whereas high-flow nasal oxygen is protective.

Autoimmune Disease in Parent Tied to Allergy Risk in Child

Having a parent with an autoimmune disease may be associated with an increased risk for allergic diseases, a meta-analysis shows.

GLP-1 Drugs Under Scrutiny: How Real Are the Risks?

Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence.

Early Warning Scores Fairly Accurate in Older Adults in ED

Early warning scores fairly predict 24-h deterioration in adults aged 80 years or older in the emergency department, with the Rapid Emergency Medicine Score more consistent and improving with age.

Mediterranean Diet Linked to Lower Adult-Onset Asthma Risk

Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking cessation, exercise, weight control, and exposure reduction.

Abrocitinib Effective for Hand Eczema in Phase 2 Study

In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK inhibitor.

Ciprofloxacin for Transplant Prophylaxis: Time to Rethink?

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is tied to higher rates of antimicrobial resistance and antibiotic use.

Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

Recommended News For You

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

Routine breast cancer screening can bring better outcomes for patients

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

New CAR T-Cell Therapy Approved for Leukemia

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

Recommended Articles For You

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma 

Unlocking Life Expectancy After Subdural Hematoma: A New Hope 

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer 

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

2.

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

3.

Sydney researchers identify new tools to improve cancer diagnosis and treatment.

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

How wildfires pose challenges to cancer care

1.

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients

2.

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances

3.

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Understanding the Importance of CA125: A Comprehensive Guide 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

3.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot